|
13 Companies |
|
19 Products |
|
19 Products |
|
12 Mechanisms of Action |
|
0 Trials |
|
229 News |
|
| «12345 |
- Trial withdrawal: Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of South Florida
Terminated --> Withdrawn
- Enrollment change: Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of South Florida
Terminated --> Withdrawn N=80 --> 0
- Trial completion: Validation of the Facial and Cephalic Pain Inventory (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=68, Completed, Sponsor: Greg Davis
N=80 --> 0 Active, not recruiting --> Completed
- |||||||||| New P3 trial: Study Evaluating the Safety of Intranasal Administration of 400 ?g of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps (clinicaltrials.gov) - Jun 17, 2012
P3, N=700, Recruiting, Sponsor: Optinose US Inc.
- |||||||||| Xhance (fluticasone propionate intranasal spray) / OptiNose
New P3 trial: 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device (clinicaltrials.gov) - Jun 17, 2012
P3, N=200, Recruiting, Sponsor: Optinose US Inc.
- | New P1 trial: Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium (clinicaltrials.gov) - Jun 17, 2012
P1, N=40, Active, not recruiting, Sponsor: SinuSys Corporation
- Trial completion: The Effect of Packing in Post Operative Management of FESS (clinicaltrials.gov) - Jun 1, 2012
P4, N=66, Completed, Sponsor: Tehran University of Medical Sciences
Active, not recruiting --> Completed Recruiting --> Completed
- tranexamic acid IV / Generic mfg.
Trial completion, Surgery: Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery (clinicaltrials.gov) - Apr 24, 2012
P=N/A, N=28, Completed, Sponsor: University of Alberta
Recruiting --> Completed Recruiting --> Completed
- Trial withdrawal, Surgery: Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus Surgery (clinicaltrials.gov) - Apr 11, 2012
P=N/A, N=0, Withdrawn, Sponsor: Lahey Clinic
Recruiting --> Completed Terminated --> Withdrawn
- Enrollment change, Surgery: Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus Surgery (clinicaltrials.gov) - Apr 11, 2012
P=N/A, N=0, Withdrawn, Sponsor: Lahey Clinic
Terminated --> Withdrawn N=138 --> 0
- Xolair (omalizumab) / Roche, Novartis
Enrollment change: Xolair in Patients With Chronic Sinusitis (clinicaltrials.gov) - Apr 11, 2012
P4, N=14, Completed, Sponsor: University of Chicago
N=138 --> 0 N=50 --> 14
- Xolair (omalizumab) / Roche, Novartis
Trial completion: Xolair in Patients With Chronic Sinusitis (clinicaltrials.gov) - Apr 11, 2012
P4, N=14, Completed, Sponsor: University of Chicago
N=50 --> 14 Active, not recruiting --> Completed
- ||||| New P4 trial, Surgery: Saline Irrigation After Surgery in Patients With Chronic Sinusitis (clinicaltrials.gov) - Apr 9, 2012
P4, N=86, Completed, Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- | dexmedetomidine / Generic mfg.
Surgery: Randomized Controlled Trial to Evaluate of Dexmedetomidine for the Effect on Operative Visibility in Patients Undergoing Endoscopic Sinus Surgery (clinicaltrials.gov) - Mar 29, 2012
P4, N=66, Completed, Sponsor: Yonsei University
- Trial initiation date, HEOR, Surgery: CHEC: Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis (clinicaltrials.gov) - Mar 22, 2012
P4, N=200, Terminated, Sponsor: Johnson & Johnson Medical Companies
Active, not recruiting --> Completed Initiation date: Nov 2011 --> Feb 2012
- | Trial completion: SToSS: Sinuclean's Treatment Of Sinusitis' Symptoms (clinicaltrials.gov) - Mar 11, 2012
P4, N=49, Completed, Sponsor: Galsor S.r.l.
Initiation date: Nov 2011 --> Feb 2012 Recruiting --> Completed
- gentamicin sulfate / Generic mfg.
Trial withdrawal, Surgery: Nasospore Stent For Use in Enodscopic Sinus Surgery (clinicaltrials.gov) - Feb 15, 2012
P4, N=0, Withdrawn, Sponsor: Lahey Clinic
Recruiting --> Completed Terminated --> Withdrawn
- gentamicin sulfate / Generic mfg.
Enrollment change, Surgery: Nasospore Stent For Use in Enodscopic Sinus Surgery (clinicaltrials.gov) - Feb 15, 2012
P4, N=0, Withdrawn, Sponsor: Lahey Clinic
Terminated --> Withdrawn N=100 --> 0
- Enrollment open: Sinusitis in Children and the Nasopharyngeal Microbiome (clinicaltrials.gov) - Feb 13, 2012
P=N/A, N=355, Recruiting, Sponsor: University of Wisconsin, Madison
N=100 --> 0 Not yet recruiting --> Recruiting
- Trial completion: Point-of-Care Computed Tomography (CT) Chronic Rhinosinusitis Study (clinicaltrials.gov) - Jan 16, 2012
P=N/A, N=40, Completed, Sponsor: Northwestern University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | New P4 trial, HEOR, Surgery: CHEC: Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis (clinicaltrials.gov) - Oct 18, 2011
P4, N=200, Terminated, Sponsor: Johnson & Johnson Medical Companies
- | Pulmozyme (dornase alfa) / Roche
Enrollment closed: Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis (clinicaltrials.gov) - Sep 28, 2011
P2, N=20, Active, not recruiting, Sponsor: University of Vermont
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- gentamicin sulfate / Generic mfg.
Clinical: Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis (clinicaltrials.gov) - Sep 4, 2011
P=N/A, N=40, Recruiting, Sponsor: Mahidol University
- New P4 trial: FISHNET: Medicated Punctured-Glove-Finger Spacer Study (clinicaltrials.gov) - Aug 17, 2011
P4, N=50, Completed, Sponsor: St. Paul's Hospital, Canada